» Articles » PMID: 34910184

Burden of Serious Bacterial Infections and Multidrug-Resistant Organisms in an Adult Population of Nepal: A Comparative Analysis of Minimally Invasive Tissue Sampling Informed Mortality Surveillance of Community and Hospital Deaths

Overview
Journal Clin Infect Dis
Date 2021 Dec 15
PMID 34910184
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Bacterial diseases are the leading cause of mortality globally, and due to haphazard use of antibiotics, antimicrobial resistance has become an emerging threat.

Methods: This cross-sectional observational study utilized a minimally invasive tissue sampling procedure to determine the cause of death among an adult population. Bacterial cultures (blood, cerebrospinal fluid, lung tissue) and antibiotic susceptibility were evaluated, and the results were compared between community and hospital deaths.

Results: Of 100 deceased persons studied, 76 (76%) deaths occurred in the community and 24 (24%) in the hospital. At least 1 bacterial agent was cultured from 86 (86%) cases; of these, 74 (86%) had a bacterial disease attributed as the primary cause of death, with pneumonia (35, 47.3%), sepsis (33, 44.6%), and meningitis (3, 4.1%) most common. Of 154 bacterial isolates (76.6% from the community and 23.4% from the hospital) detected from 86 culture-positive cases, 26 (16.8%) were multidrug-resistant (MDR). Klebsiella species were the most common (13 of 26) MDR organisms. The odds of getting an MDR Klebsiella infection was 6-fold higher among hospital deaths compared with community deaths (95% confidence interval [CI], 1.37-26.40; P = .017) and almost 23-fold higher (CI, 2.45-213.54; P = .006) among cases with prior antibiotic use compared to those without.

Conclusions: High incidence of serious bacterial infections causing death of adults in the community, with most MDR organisms isolated from hospitalized cases, calls for robust surveillance mechanisms and infection prevention activities at the community level and evidence-driven antibiotic stewardship in healthcare settings.

Citing Articles

A Six Years' Trend Analysis of Antimicrobial Resistance Among Bacterial Isolates at Public Health Institute in Amhara Region, Ethiopia.

Abejew A, Gedif Fenta T, Wubetu G Biomed Res Int. 2025; 2025:7676973.

PMID: 39949375 PMC: 11824853. DOI: 10.1155/bmri/7676973.


From green chemistry to biomedicine: the sustainable symphony of cobalt oxide nanoparticles.

Annu , Sahu M, Singh S, Prajapati S, Verma D, Shin D RSC Adv. 2024; 14(45):32733-32758.

PMID: 39429933 PMC: 11483901. DOI: 10.1039/d4ra05872k.


-Venom-Loaded Cross-Linked Chitosan Nanoparticles Improve Antimicrobial Activity.

Glaucia-Silva F, Torres J, Torres-Rego M, Daniele-Silva A, Furtado A, Ferreira S Int J Mol Sci. 2024; 25(18).

PMID: 39337380 PMC: 11432167. DOI: 10.3390/ijms25189893.


Assessment of challenges and opportunities in antibiotic stewardship program implementation in Northwest Ethiopia.

Abejew A, Wubetu G, Gedif Fenta T Heliyon. 2024; 10(11):e32663.

PMID: 38912506 PMC: 11193037. DOI: 10.1016/j.heliyon.2024.e32663.


Carvacrol and Thymol Hybrids: Potential Anticancer and Antibacterial Therapeutics.

Peter S, Sotondoshe N, Aderibigbe B Molecules. 2024; 29(10).

PMID: 38792138 PMC: 11123974. DOI: 10.3390/molecules29102277.


References
1.
. Five insights from the Global Burden of Disease Study 2019. Lancet. 2020; 396(10258):1135-1159. PMC: 7116361. DOI: 10.1016/S0140-6736(20)31404-5. View

2.
Paganelli C, Goco N, McClure E, Banke K, Blau D, Breiman R . The evolution of minimally invasive tissue sampling in postmortem examination: a narrative review. Glob Health Action. 2020; 13(1):1792682. PMC: 7480574. DOI: 10.1080/16549716.2020.1792682. View

3.
Subedi N, Bhattarai S, Ranabhat S, Sharma B, Baral M, Upadhyaya T . Disseminated cryptococcosis in a deceased with HIV-1 diagnosed by minimally invasive tissue sampling technique. Clin Case Rep. 2021; 9(3):1667-1671. PMC: 7981628. DOI: 10.1002/ccr3.3865. View

4.
Morita J, Zell E, Danila R, Farley M, Hadler J, Harrison L . Association between antimicrobial resistance among pneumococcal isolates and burden of invasive pneumococcal disease in the community. Clin Infect Dis. 2002; 35(4):420-7. DOI: 10.1086/341897. View

5.
Mendelson M, Rottingen J, Gopinathan U, Hamer D, Wertheim H, Basnyat B . Maximising access to achieve appropriate human antimicrobial use in low-income and middle-income countries. Lancet. 2015; 387(10014):188-98. DOI: 10.1016/S0140-6736(15)00547-4. View